| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.5B | $16.6B | $15.8B | $11.7B | $12.8B | $3.4B | $2.6B | $1.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.2B | $3.7B | $2.9B | $-0.1B | $3.2B | $1.3B | $2.5B | $0.0B |
| Net Income | $2.1B | $2.7B | $2.0B | $-0.2B | $2.4B | $0.8B | $0.5B | $-0.8B |
| EPS (Basic) | $169.74 | $199.69 | $147.32 | $-23.57 | $176.92 | $59.44 | $36.34 | $-53.88 |
| EPS (Diluted) | $169.22 | $199.32 | $146.98 | $-23.57 | $176.51 | $59.33 | $36.26 | $-53.88 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $68.9B | $61.9B | $55.0B | $49.8B | $48.4B | $41.7B | $37.5B | $33.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $4.0B | $3.7B | $3.7B | $4.1B | $4.0B | $4.3B | $3.1B | $2.0B |
| Total Liabilities | $49.8B | $44.4B | $39.5B | $36.1B | $33.3B | $28.6B | $26.2B | $24.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $18.6B | $16.9B | $15.0B | $13.1B | $14.7B | $12.8B | $11.1B | $9.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.8B | $2.6B | $2.8B | $2.7B | $2.3B | $1.7B | $1.3B | $0.9B |
| Investing Cash Flow | $-1.2B | $-2.4B | $-2.7B | $-1.7B | $-2.9B | $-0.5B | $-0.5B | $-0.8B |
| Capital Expenditures | $0.2B | $0.3B | $0.3B | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-1.2B | $-0.3B | $-1.0B | $-0.6B | $0.4B | $0.4B | $0.4B | $-0.2B |